AMRN Stock Summary and Trading Ideas (Amarin PLC - American Depositary Shares | NASDAQ:AMRN)

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Amarin PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AMRN.

As of April 30, 2026, AMRN stock price declined to $13.93 with 116,603 million shares trading.

AMRN has a beta of 1.22, meaning it tends to be more sensitive to market movements. AMRN has a correlation of 0.10 to the broad based SPY ETF.

AMRN has a market cap of $292.15 million. This is considered a Small Cap stock.

Last quarter Amarin PLC - American Depositary Shares reported $45 million in Revenue and $.00 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.41.

In the last 3 years, AMRN traded as high as $29.70 and as low as $7.08.

The top ETF exchange traded funds that AMRN belongs to (by Net Assets): SPDW, GWX.

AMRN has outperformed the market in the last year with a return of +34.8%, while the SPY ETF gained +31.0%. However, in the most recent history, AMRN shares have underperformed the stock market with its stock returning -9.7% in the last 3 month period and -8.4% for the last 2 week period, while SPY has returned +3.8% and +2.7%, respectively.

AMRN support price is $13.86 and resistance is $14.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRN shares will trade within this expected range on the day.